
    
      We project to include in the study a maximum of 168 patients with a recent (5 to 10 days)
      ischemic stroke and unilateral motor deficit in order to obtain 100 completed patients. Nine
      stroke centers in France are involved.

      Each patient will receive daily, during three months, 20 mg of fluoxetin or placebo.

      Patients will be evaluated at inclusion, day 30, M3 (3 months), M12.
    
  